Next Generation Therapies

Paul E Holtzheimer, M.D., M.S.
Paul E Holtzheimer, M.D., M.S.
April 18, 2012

The first placebo-controlled trial to verify the effectiveness and safety of deep brain stimulation (DBS) as a treatment for severe, treatment-resistant depression was reported by a team led by NARSAD Grantee Paul E....

Carlos A. Zarate, Jr
Carlos A. Zarate, Jr
April 18, 2012

In the most recent series of experiments with the potential to revolutionize the treatment of mood disorders, a team led by NARSAD Independent Investigator Grantee Carlos A. Zarate, Jr., M.D., successfully replicated a...

Helen Mayberg, M.D.
Helen Mayberg, M.D.
April 18, 2012

Watch Video Here

Deep Brain Stimulation (DBS) is a newer treatment option for patients with severe depression. Using pulses of current, DBS regulates specific areas of the brain (DBS is often referred to as the '...

Aaron T. Beck, M.D. emeritus prof., Dept. of Psych. at the UPENN
Aaron T. Beck, M.D.
March 23, 2012

NARSAD distinguished Investigator Grantee, Aaron T. Beck, the 'Father of Cognitive Behavioral Therapy (CBT)’ proved that it can be used to help treat the 'negative' symptoms of schizophrenia. CBT was invented by Beck in...

Rene Hen, Ph.D., Departments of Psychiatry Neuroscience at Columbia University
Rene Hen, Ph.D.
March 21, 2012

In 2010, Scientific Council Member Rene Hen, Ph.D., professor of pharmacology in the Departments of Psychiatry and Neuroscience at Columbia University, and a researcher at the New York State Psychiatric Institute, led a...

Pages

Subscribe to